The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) Study
Abstract
TEST 02 - Elsevier's Scopus, the largest abstract and citation database of peer-reviewed literature. Search and access research from the science, technology, medicine, social sciences and arts and humanities fields.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the GREACE study, statin therapy with atorvastatin improved cardiovascular outcomes in patients with metabolic syndrome.
“In the GREACE study [70], statin therapy with atorvastatin (10–80 mg/day) reduced LDL-C by 41% and TG by 28% in patients with metabolic syndrome, leading to improved cardiovascular outcomes.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [70]
In the GREACE study, atorvastatin (10-80 mg/day) reduced LDL-C by 41% and TG by 28% in patients with metabolic syndrome.
“In the GREACE study [70], statin therapy with atorvastatin (10–80 mg/day) reduced LDL-C by 41% and TG by 28% in patients with metabolic syndrome, leading to improved cardiovascular outcomes.”
From Targeting triglycerides for cardiovascular risk reduction (2026) · cites this paper as [70]
Cites
Rubins, H. B., Robins, S. J., Collins, D., Fye, C. L., Anderson, J. W., Elam, M. B., Faas, F. H., Linares, E., Schaefer, E. J., Schectman, G., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908053410604 · Cited by 3,439 · see citing works
Collins, R., Armitage, J., Parish, S., Sleight, P., & Peto, R. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12475-0 · Cited by 492 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Stone, N. J., Robinson, J. G., Lichtenstein, A. H., Bairey Merz, C. N., Blum, C. B., Eckel, R. H., Goldberg, A. C., Gordon, D., Levy, D., Lloyd-Jones, D. M., et al. (2014) · Circulation · doi:10.1161/01.cir.0000437738.63853.7a · Cited by 7,081 · see citing works
Collaborators, C. T. T. (. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60367-5 · Cited by 2,833 · see citing works
Collaborators, C. T. T. (. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60104-x · Cited by 2,081 · see citing works
Mills, E. J., WU, P., Chong, G., Ghement, I., Singh, S., Akl, E. A., Eyawo, O., Guyatt, G., Berwanger, O., & Briel, M. (2011) · QJM · doi:10.1093/qjmed/hcq165 · Cited by 338 · see citing works
Lu, Z., Kou, W., Du, B., Wu, Y., Zhao, S., Brusco, O. A., Morgan, J. M., & Capuzzi, D. M. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.02.056 · Cited by 315 · see citing works
McKinney, J. S., & Kostis, W. J. (2012) · Stroke · doi:10.1161/strokeaha.112.655894 · Cited by 294 · see citing works
Charytan, D., & Kuntz, R. E. (2006) · Kidney International · doi:10.1038/sj.ki.5001934 · Cited by 271 · see citing works
Preiss, D., Campbell, R. T., Murray, H. M., Ford, I., Packard, C. J., Sattar, N., Rahimi, K., Colhoun, H. M., Waters, D. D., LaRosa, J. C., et al. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv072 · Cited by 160 · see citing works
Athyros, V. G., Papageorgiou, A. A., Symeonidis, A. N., Didangelos, T. P., Pehlivanidis, A. N., Bouloukos, V. I., & Mikhailidis, D. P. (2003) · Angiology · doi:10.1177/000331970305400607 · Cited by 85 · see citing works
Self-citationTargeting triglycerides for cardiovascular risk reduction
Maiorca, C., Tramontano, D., Di Costanzo, A., & D’Erasmo, L. (2026) · Internal and Emergency Medicine · doi:10.1007/s11739-026-04383-1
- Authors
- Mikhailidis, D. P., & Wierzbicki, A. S.
- Affiliations
- The Royal Free Hospital (GB)
- St Thomas' Hospital (GB)
- Corresponding author
- Mikhailidis, Dimitri P.
- Venue
- Current Medical Research and Opinion
- Publisher
- Informa UK Limited
- Published
- 2002-01
- Volume
- 18
- Issue
- 4
- Pages
- 215-219
- ISSN
- 0300-7995 (ISSN-L)
- 1473-4877
- OpenAlex
- W2114711336
- Cited by
- 124
- References
- 3
- Citations by year
- 2026: 1 · 2023: 1 · 2021: 1 · 2018: 1 · 2017: 1 · 2016: 1 · 2015: 4 · 2014: 6 · 2013: 6 · 2012: 7
- FWCI
- 14.00
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Current Medical Research and Opinion (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Surgery › Lipoproteins and Cardiovascular Health
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Antiplatelet Therapy and Cardiovascular Diseases
- Keywords
- atorvastatin, coronary artery disease, statin therapy, lipid-lowering therapy, secondary prevention
- MeSH terms
- Atorvastatin, Adult, Aged, Anticholesteremic Agents, Coronary Disease, Female, Greece, Heptanoic Acids, Humans, Cholesterol, HDL, Cholesterol, LDL, Male, Middle Aged, National Health Programs, Pyrroles, Triglycerides, Cholesterol, VLDL, Randomized Controlled Trials as Topic, Treatment Outcome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
